Synapse Open Synapse
Biology

Top biotech deals in October 2026

Labiotech.eu · · 8 min read

The most expensive biotech M&A in October 2026 was worth $2 billion. Licensing deals spanned across therapeutic technologies.

Latest from Labiotech.eu